Axonics receives US FDA approval for fourth-generation rechargeable sacral neuromodulation system
Axonics has announced that the US Food and Drug Administration has approved the company’s fourth-generation […]
Axonics has announced that the US Food and Drug Administration has approved the company’s fourth-generation […]
Abbott has announced that the US Food and Drug Administration (FDA) has approved its Proclaim […]
Combination spinal cord stimulation (SCS) therapy with Boston Scientific’s WaveWriter system has demonstrated superior outcomes […]
A double-blinded randomized controlled trial (RCT) has shown that transcutaneous auricular vagus nerve stimulation (taVNS) […]
The CELLO II balloon guide catheter (Fuji Systems Corporation) has received 510(k) premarket approval from […]
New York-based brain-computer interface company Precision Neuroscience Corporation closed $41 million in Series B funding, […]
Blackford—an artificial intelligence (AI) imaging platform and solutions provider—is set to form a strategic partnership […]
Researchers have explored the therapeutic outcomes of patients with brain arteriovenous malformations (AVMs) in mainland […]
A new VR programme with interactive sight, sound, and touch experiences has helped improve outcomes […]
Researchers at Linköping University in Sweden have developed artificial neurons that demonstrate 15 of the […]
Basecamp Vascular (BCV) has announced the appointment of Thierry Col as its new CEO, effective […]
The “renaissance” of neuro- and cerebroprotective paradigms, coupled with “the advent of new ideas”—such as […]
Gentuity has today announced the first human use of the Vis-M high-frequency optical coherence tomography […]
Medtronic has announced that it will highlight clinical and preclinical research relating to sensing-enabled spinal […]
Synchron has announced that the medical journal JAMA Neurology has published peer-reviewed, long-term safety results […]
A recent update on the DISTAL randomised controlled trial (RCT)—which was delivered at the Barts […]
Researchers from India have developed a patient-specific mathematical model to examine and elucidate the parameters—including […]
Nevro Corporation has announced that two abstracts for clinical trials relating to painful diabetic neuropathy […]
Imagine that a soldier has a tiny computer device injected into their bloodstream that can be […]
A team including researchers from the USA, Germany and Canada has found that stimulating a […]
Synchron has announced the first human brain-computer interface (BCI) implant in the USA. This procedure […]
Frontotemporal dementia (FTD) or frontotemporal lobar degeneration (FTLD) is a rare, rapidly progressing neurodegenerative disease […]
Stryker recently opened its Neurovascular (NV) lab—a “state-of-the-art” laboratory designed to accelerate stroke-related innovation in […]
Dive Brief: The investment arms of billionaires Jeff Bezos and Bill Gates joined a $75 […]
NeuroOne Medical today announced it completed a feasibility study of its OneRF ablation system. The feasibility […]
“We are entering an era where true scientific evidence from IONM [intraoperative neuromonitoring] is guiding […]
Johns Hopkins University researchers have developed new models for mapping epileptic seizures. The models could help […]
Wise announced today that it received FDA clearance for its Wise Cortical Strip (WCS) for […]
Abbott has been recognized by the Consumer Technology Association (CTA) with three Consumer Electronics Show […]
Viz.ai has announced a strategic partnership with full-service, vascular clinical research organization (CRO) Vastrax. Together, […]
Johnson & Johnson (NYSE:JNJ) has released results for its Embotrap stent retrievers showing the next-generation design’s […]
Onward, a medical technology company creating therapies to restore movement and health in people with […]
Cerenovus, part of Johnson & Johnson MedTech, has today announced positive primary outcomes from the […]
Contego Medical has announced that enrolment of the PERFORMANCE II clinical trial has been completed. […]
Researchers at the University of Connecticut recently shared their development of a new method for […]
CVRx—the developer of the “world’s first” US Food and Drug Administration (FDA)-approved neuromodulation device to […]
In a new paper published in Light: Science and Applications, a team of scientists and […]
RapidAI has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the […]
Researchers at the University of California-San Francisco have developed a neuroprosthesis that decodes brain activity […]
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.